Lokavant Raises $21M in Funding
Lokavant, a Princeton, NJ-based scientific trial intelligence firm raised $21M in funding.
The spherical was led by Edison Companions with participation from Roivant Sciences (Nasdaq:?ROIV). As a part of the transaction, Edison’s Common Companion,?Gregg Michaelson, will be a part of Lokavant’s board of administrators.
The corporate intends to make use of the funds to scale its business groups, and speed up function improvement for its platform, which offers intelligence for scientific trials from planning to execution
Led by CEO Rohit Nambisan, Lokavant is a scientific intelligence platform that permits the real-time integration and harmonization of all scientific trial information for examine planning and operations. The answer aggregates and integrates real-time information from disparate trial information sources, and powers superior analytics enabled by its compendium of proprietary trial information. The suite of functions constructed on the system permits examine groups to proactively plan and handle their research and floor insights, driving efficiencies in all scientific and operational use instances. Medical researchers entry the platform through use-case-specific functions, with a product portfolio encompassing data-driven examine planning, benchmarking, operational well being assessments, threat detection, medical monitoring, and vendor oversight, all incorporating Lokavant’s proprietary information set into planning and monitoring.
Shishir Gupta, The Founder & CEO of StartupLanes said,
Lokavant Raises $21M in Funding. May this new business bring you huge success and fulfillment.
About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.
Startups looking for funding may apply through?StartupLanes Funding Application.